PT1446119E - Substancias que contem ipratropio e xilometazolina na sua composicao para o tratamento da constipacao comum - Google Patents
Substancias que contem ipratropio e xilometazolina na sua composicao para o tratamento da constipacao comumInfo
- Publication number
- PT1446119E PT1446119E PT02765268T PT02765268T PT1446119E PT 1446119 E PT1446119 E PT 1446119E PT 02765268 T PT02765268 T PT 02765268T PT 02765268 T PT02765268 T PT 02765268T PT 1446119 E PT1446119 E PT 1446119E
- Authority
- PT
- Portugal
- Prior art keywords
- xylometazolin
- treatment
- composition
- substances containing
- common constitution
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 229960001888 ipratropium Drugs 0.000 title abstract 2
- OEXHQOGQTVQTAT-SSZRJXQFSA-N [(1r,5s)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] (2r)-3-hydroxy-2-phenylpropanoate Chemical compound C1([C@H](CO)C(=O)OC2C[C@H]3CC[C@@H](C2)[N+]3(C)C(C)C)=CC=CC=C1 OEXHQOGQTVQTAT-SSZRJXQFSA-N 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- YGWFCQYETHJKNX-UHFFFAOYSA-N 2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1h-imidazol-3-ium;chloride Chemical compound [Cl-].CC1=CC(C(C)(C)C)=CC(C)=C1CC1=NCC[NH2+]1 YGWFCQYETHJKNX-UHFFFAOYSA-N 0.000 abstract 1
- 208000036071 Rhinorrhea Diseases 0.000 abstract 1
- 206010039101 Rhinorrhoea Diseases 0.000 abstract 1
- 239000000812 cholinergic antagonist Substances 0.000 abstract 1
- OEXHQOGQTVQTAT-JRNQLAHRSA-N ipratropium Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 OEXHQOGQTVQTAT-JRNQLAHRSA-N 0.000 abstract 1
- 210000002850 nasal mucosa Anatomy 0.000 abstract 1
- 201000009240 nasopharyngitis Diseases 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 239000005526 vasoconstrictor agent Substances 0.000 abstract 1
- 229960001095 xylometazoline hydrochloride Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Polyurethanes Or Polyureas (AREA)
- Cosmetics (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200101356 | 2001-09-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1446119E true PT1446119E (pt) | 2006-07-31 |
Family
ID=8160714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT02765268T PT1446119E (pt) | 2001-09-18 | 2002-09-18 | Substancias que contem ipratropio e xilometazolina na sua composicao para o tratamento da constipacao comum |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US7652030B2 (enExample) |
| EP (2) | EP1661570A3 (enExample) |
| JP (1) | JP4500045B2 (enExample) |
| KR (1) | KR100810872B1 (enExample) |
| CN (1) | CN1290502C (enExample) |
| AT (1) | ATE318601T1 (enExample) |
| BR (1) | BRPI0212586B8 (enExample) |
| CA (1) | CA2460140C (enExample) |
| DE (1) | DE60209511T2 (enExample) |
| DK (1) | DK1446119T3 (enExample) |
| EA (1) | EA008165B1 (enExample) |
| ES (1) | ES2259098T3 (enExample) |
| HU (1) | HU226527B1 (enExample) |
| MX (1) | MXPA04002500A (enExample) |
| NO (1) | NO334441B1 (enExample) |
| NZ (1) | NZ531792A (enExample) |
| PL (1) | PL208686B1 (enExample) |
| PT (1) | PT1446119E (enExample) |
| SI (1) | SI1446119T1 (enExample) |
| WO (1) | WO2003024433A2 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
| CN1290502C (zh) * | 2001-09-18 | 2006-12-20 | 丹麦奈科明有限公司 | 治疗普通感冒的组合物 |
| TWI359675B (en) * | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
| EP1713472A2 (en) * | 2004-02-06 | 2006-10-25 | MEDA Pharma GmbH & Co. KG | Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids |
| WO2005084330A2 (en) * | 2004-03-02 | 2005-09-15 | Synergia Pharma, Inc. | Compositions and methods for treating nasal congestion |
| DE102004049008A1 (de) | 2004-10-05 | 2006-04-06 | Merck Patent Gmbh | Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur |
| NZ555693A (en) * | 2004-12-27 | 2010-10-29 | Eisai R&D Man Co Ltd | Matrix type sustained-release preparation containing donepezil |
| DE102006023770A1 (de) * | 2006-05-20 | 2007-11-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Treibgasfreie Aerosolformulierung für die Inhalation |
| EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
| US20090270472A1 (en) * | 2008-04-25 | 2009-10-29 | Kenneth Gould | Method to use oxymetazoline to interrupt the development of the common cold syndrome |
| WO2010112358A2 (de) | 2009-03-31 | 2010-10-07 | Boehringer Ingelheim International Gmbh | Verfahren zur beschichtung einer oberfläche eines bauteils |
| WO2010133294A2 (de) | 2009-05-18 | 2010-11-25 | Boehringer Ingelheim International Gmbh | Adapter, inhalationseinrichtung und zerstäuber |
| EA026241B1 (ru) | 2009-11-25 | 2017-03-31 | Бёрингер Ингельхайм Интернациональ Гмбх | Распылитель |
| EP2504051B1 (en) | 2009-11-25 | 2019-09-04 | Boehringer Ingelheim International GmbH | Nebulizer |
| US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
| JP5874724B2 (ja) | 2010-06-24 | 2016-03-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
| EP2694220B1 (de) | 2011-04-01 | 2020-05-06 | Boehringer Ingelheim International GmbH | Medizinisches gerät mit behälter |
| US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
| WO2014158119A1 (en) * | 2013-03-29 | 2014-10-02 | Santa Farma İlaç Sanayi̇ A.Ş | Aqueous solution composition containing ipratropium and oxymetazoline |
| WO2014158118A1 (en) * | 2013-03-29 | 2014-10-02 | Santa Farma İlaç Sanayi̇ A.Ş. | Suspension composition containing ipratropium and oxymetazoline |
| PL2835146T3 (pl) | 2013-08-09 | 2021-04-06 | Boehringer Ingelheim International Gmbh | Nebulizator |
| EP3030298B1 (en) | 2013-08-09 | 2017-10-11 | Boehringer Ingelheim International GmbH | Nebulizer |
| WO2015054359A1 (en) * | 2013-10-08 | 2015-04-16 | Ebadi Mark A | Methods and compositions for symptomatic reflief of the common cold |
| AU2015257878B2 (en) | 2014-05-07 | 2019-08-08 | Boehringer Ingelheim International Gmbh | Container, nebulizer and use |
| EA033013B1 (ru) | 2014-05-07 | 2019-08-30 | Бёрингер Ингельхайм Интернациональ Гмбх | Контейнер, индикаторное устройство и небулайзер |
| EP3139984B1 (en) | 2014-05-07 | 2021-04-28 | Boehringer Ingelheim International GmbH | Nebulizer |
| EA032719B1 (ru) * | 2014-12-24 | 2019-07-31 | Ярдан-Галенски Лабораторий Д.Д. | Назальная лекарственная форма против заложенности носа |
| MX383771B (es) * | 2015-12-02 | 2025-03-14 | Pablo Cortes Borrego | Combinación de oximetazolina e ipratropio en aplicación tópica nasal para el tratamiento de la tos. |
| US20220031739A1 (en) * | 2020-07-31 | 2022-02-03 | Eye Therapies Llc | Anti-viral compositions and methods of use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2137981T3 (es) * | 1991-11-19 | 2000-01-01 | Univ Virginia | Tratamiento combinado por agentes antimediaticos y antiviricos de resfriados comunes. |
| IL101056A (en) * | 1992-02-24 | 1997-03-18 | Res & Dev Co Ltd | Composition for nasal treatment |
| GB9218834D0 (en) | 1992-09-05 | 1992-10-21 | Procter & Gamble | Nasal spray products |
| JP3009924B2 (ja) | 1992-12-09 | 2000-02-14 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 安定化医用エアーゾル溶液製剤 |
| EP0780127A1 (en) | 1995-12-19 | 1997-06-25 | The Procter & Gamble Company | A nasal spray containing a steroid and a antihistamine |
| DE19653969A1 (de) * | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Kg | Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole |
| AU6878098A (en) * | 1997-04-30 | 1998-11-24 | Warner-Lambert Company | Topical nasal antiinflammatory compositions |
| NZ505919A (en) * | 1998-01-30 | 2002-10-25 | Novartis Consumer Health S | Nasal solutions |
| ME00838B (me) | 1998-06-18 | 2008-09-29 | Boehringer Ingelheim Pharmaceuticals Inc | Farmaceutske formulacije za aerosolove sa dve ili više aktivnih supstanci |
| WO2000078297A2 (de) * | 1999-06-22 | 2000-12-28 | Boehringer Ingelheim International Gmbh | Stabile xylometazolin- und oxymetazolinlösung |
| CN1290502C (zh) * | 2001-09-18 | 2006-12-20 | 丹麦奈科明有限公司 | 治疗普通感冒的组合物 |
-
2002
- 2002-09-18 CN CNB028182871A patent/CN1290502C/zh not_active Expired - Lifetime
- 2002-09-18 KR KR1020047003882A patent/KR100810872B1/ko not_active Expired - Lifetime
- 2002-09-18 PL PL370536A patent/PL208686B1/pl unknown
- 2002-09-18 CA CA002460140A patent/CA2460140C/en not_active Expired - Lifetime
- 2002-09-18 DE DE60209511T patent/DE60209511T2/de not_active Expired - Lifetime
- 2002-09-18 JP JP2003528530A patent/JP4500045B2/ja not_active Expired - Lifetime
- 2002-09-18 AT AT02765268T patent/ATE318601T1/de active
- 2002-09-18 MX MXPA04002500A patent/MXPA04002500A/es active IP Right Grant
- 2002-09-18 EA EA200400444A patent/EA008165B1/ru unknown
- 2002-09-18 EP EP06075452A patent/EP1661570A3/en not_active Withdrawn
- 2002-09-18 BR BRPI0212586A patent/BRPI0212586B8/pt not_active IP Right Cessation
- 2002-09-18 ES ES02765268T patent/ES2259098T3/es not_active Expired - Lifetime
- 2002-09-18 HU HU0402075A patent/HU226527B1/hu unknown
- 2002-09-18 US US10/489,655 patent/US7652030B2/en not_active Expired - Lifetime
- 2002-09-18 SI SI200230311T patent/SI1446119T1/sl unknown
- 2002-09-18 DK DK02765268T patent/DK1446119T3/da active
- 2002-09-18 PT PT02765268T patent/PT1446119E/pt unknown
- 2002-09-18 EP EP02765268A patent/EP1446119B1/en not_active Expired - Lifetime
- 2002-09-18 NZ NZ531792A patent/NZ531792A/en not_active IP Right Cessation
- 2002-09-18 WO PCT/IB2002/003828 patent/WO2003024433A2/en not_active Ceased
-
2004
- 2004-03-12 NO NO20041070A patent/NO334441B1/no not_active IP Right Cessation
-
2009
- 2009-12-11 US US12/654,145 patent/US8450339B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1446119E (pt) | Substancias que contem ipratropio e xilometazolina na sua composicao para o tratamento da constipacao comum | |
| BR9812361A (pt) | Uso de combinações compreendendo anti-histaminas não-sedantes e drogas alfa-adrenérgicas para o tratamento tópico de rinite/conjutivite e sintomas de infecção por vìrus, semelhante a infecção por vìrus e/ou resfriado | |
| BR0009564A (pt) | Utilização de inibidores da cyp2d6 em terapias de combinação | |
| BR9911666A (pt) | Combinação farmacêutica, uso da combinação, processo para tratamento de uma doença inflamatória em uma pessoa sofrendo de ou susceptìvel a tal doença, e, composição farmacêutica | |
| AR033548A1 (es) | Composicion farmaceutica que comprende un inhibidor de lipasa, un procedimiento para su preparacion, equipo transportable a modo de ''kit'', el uso de dicha composicion en la fabricacion de medicamentos, un inhibidor de lipasa y un secuestrante de acidos biliares | |
| MX9505182A (es) | Composicion terapeutica para aplicacion topica, que contiene un antagonista de la substancia p. | |
| UY26704A1 (es) | Nueva composición farmacéutica | |
| BRPI0517481A (pt) | método para tratar, controlar ou evitar uma doença ou distúrbio parasìtico protozoário, e, composição farmacêutica | |
| BR0307508A (pt) | Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de tratamento de doença | |
| BR9807673A (pt) | Processos para tratar asma alérgica e dermatite em um humano e composição farmacêutica. | |
| BR0008699A (pt) | Combinações de formoterol e furoato demometasona para asma | |
| EE200300475A (et) | Türosiini kinaasi inhibiitorid, neid sisaldavad ravimkoostised ja nimetatud ühendid kasutamiseks haiguste ravis | |
| HUP0301868A2 (hu) | Gyógyászati készítmény, ami VIIa és XIII-as faktort tartalmaz | |
| BR0109779A (pt) | Soluções moleculares hidrofìlicas dispersas de carvedilol | |
| BR9810520A (pt) | Inibidor do fator xa isolado ou em combinação com um anti-agregador plaquetário, contra a trambose arterial | |
| BRPI0415753A (pt) | método para tratamento e prevenção da inflamação respiratória com um inibidor de ciclooxigenase-2 em associação com um inibidor de fosfodiesterase 4 e composições que os contêm | |
| BR0314797A (pt) | Derivados da pirimidineamida e o uso dos mesmos | |
| SE0101932D0 (sv) | Pharmaceutical combinations | |
| CO4910128A1 (es) | Tratamiento del asma y compuestos utiles para este trata- miento ta combinacion y un kit de esta combinacion | |
| SG152257A1 (en) | Topical preparation containing ambroxol | |
| CA2120062A1 (en) | Use of Sulodexide and of Medicines Containing It in the Treatment of Diabetic Nephropathy | |
| BR0209206A (pt) | Clatrato de hidrato de azitromicina com 1,2-propileno glicol, processo para a sua preparação e composição farmacêutica compreendendo o mesmo | |
| NO943288L (no) | Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer | |
| WO2003020963A3 (en) | Proteins in type 2 diabetes | |
| WO2003018535A3 (en) | Novel aminobenzoephenones |